期刊文献+

老年2型糖尿病患者尿微量清蛋白/尿肌酐与脂蛋白(a)的相关性研究 被引量:10

Association between the Urinary Microalbumin /Creatinine Ratio and Lipoprotein (a) among Elderly Type 2 Diabetic Patients
暂未订购
导出
摘要 目的探讨老年2型糖尿病(T2DM)患者尿微量清蛋白/尿肌酐(UACR)与脂蛋白(a)〔Lp(a)〕的相关性。方法选取2011年1月—2012年10月本院收治T2DM患者106例和非糖尿病的其他疾病患者30例(非糖尿病对照组)。根据UACR将T2DM患者分为糖尿病肾病组(UACR≥30 mg/g,50例)和糖尿病非肾病组(UACR<30mg/g,56例)。检测各组患者的生化指标及尿微量清蛋白,采用Pearson相关分析各指标与UACR的相关性,然后采用Logistic回归分析T2DM患者UACR的危险因素。结果 (1)3组患者低密度脂蛋白胆固醇(LDL-C)、载脂蛋白B(ApoB)、Lp(a)、尿素、肌酐、空腹血糖(FBG)、糖化血红蛋白(HbA1c)水平及UACR比较,差异均有统计学意义(P<0.05)。(2)非糖尿病对照组和糖尿病非肾病组Lp(a)水平与UACR无相关性(r=-0.290,P=0.120;r=0.163,P=0.230);糖尿病肾病组Lp(a)水平与UACR呈正相关(r=0.363,P<0.01)。(3)单因素Logistic回归分析显示,糖尿病病程、舒张压、LDL-C、ApoB、Lp(a)、HbA1c、空腹C肽(FCP)为UACR可能的危险因素(P<0.2);而多因素Logistic回归分析显示,FCP、糖尿病病程、Lp(a)为UACR的独立危险因素(P<0.05)。结论糖尿病肾病患者Lp(a)水平与UACR呈正相关,且Lp(a)水平为影响UACR的独立危险因素,提示Lp(a)可间接反映T2DM患者的肾脏损害程度。 Objective To analyze the relationship between the urinary mieroalbumin/creatinine ratio (UACR) and lipoprotein (a) [ Lp (a)]in elderly type 2 diabetic (T2DM) patients. Methods A total of 106 elderly patients with T2DM and 30 patients with other diseases who were treated in our hospital form January 2011 to October 2012, were selected as study participants. T2DM patients were divided into diabetic nephropathy group (UACR≥30 my/g, 50 cases) and non- diabetic ne- phropathy group (UACR 〈 30 my/g, 56 cases), while cases with other diseases were selected as the non -diabetic control group. The biochemical indexes and urinary mieroalbumin were detected among all cases, the correlation between indexes and UACR was analyzed by Pearson correlation analysis, risk factors for UACR among T2DM patients were analyzed by Logistic re- gression analysis. Results There were significant differences in levels of low density lipoprotein cholesterol ( LDL - C), apoli- poprotein B (ApoB), Lp (a), urea, ereatinine, fasting blood glucose (FBG), glycosylated hemoglobin (HbA1c) and UACR among three groups ( P 〈 0. 05 ) . In non - diabetic control group and non - diabetic nephropathy group, there was no cor- relation between Lp (a) level and UACR (r = -0. 290, P =0. 120; r =0. 163, P =0. 230) . In diabetic nephropathy group, Lp (a) level was positively correlated with UACR ( r =0. 363, P 〈0. 01 ) . Single factor Logistic regression analysis showed that the diabetes duration, diastolic blood pressure, levels of LDL- C, ApoB, Lp (a) , HbA1c and fasting C peptide (FCP) were possible risk factors for UACR ( P 〈 0. 2) . The multivariate Logistic regression analysis showed that FCP level, diabetes duration and Lp (a) level were independent risk factors for UACR ( P 〈 0. 05 ) . Conclusion In patients with diabetic nephropathy, Lp (a) level are positively correlated with UACR, and Lp (a) level is one of the independent risk factors for UACR, so Lp (a) level can indirectly reveal the kidney damage in T2DM patients.
作者 喻萍 朱敏
出处 《中国全科医学》 CAS CSCD 北大核心 2014年第6期619-622,共4页 Chinese General Practice
关键词 糖尿病 2型 糖尿病肾病 白蛋白尿 脂蛋白(A) 尿微量清蛋白 尿肌酐 Diabetes mellitus, type 2 Diabetic nephropathies Albuminuria Lipoprotein ( a ) Urinary mi- croalbumin/creatinine ratio
  • 相关文献

参考文献12

  • 1孙培荣,石永兵.尿白蛋白/肌酐比值对诊断早期糖尿病肾病的价值[J].国际泌尿系统杂志,2006,26(4):573-575. 被引量:39
  • 2Handelsman Y, Mechanick JI, Blonde L, et at. American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for developing a diabetes mellitus comprehensive care plan [ J ]. Endocr Pract, 2011, 17 (Suppl2): 1-53.
  • 3American Diabetes Association. Nephropathy in diabetes [ J ]. Diabetes Care, 2004, 27 (Suppl 1 ) : 79 - g3.
  • 4韩萍,刘莫敏,王艳军.2型糖尿病血管并发症与血浆脂蛋白及体液免疫水平的关系[J].中国实用内科杂志,1994,14(4):280-281.
  • 5何平,谢贤和,丁毅鹏,陈晓玲.高敏C反应蛋白、脂蛋白a、血尿酸与冠状动脉病变程度的相关性[J].中华医学杂志,2010,90(28):1989-1991. 被引量:36
  • 6Emerging Risk Factors Collaboration, Erqou S, Kaptoge S, et al. Lip- oprotein (a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality [ J ]. JAMA, 2009, 302 (4) : 412 -423.
  • 7Singla S, Kaur K, Kaur G, et al. Lipoprotein (a) in type 2 diabetes mellitus: relation to LDL: HDL ratio and glyeemie control [ J ]. Int J Diabetes Dev Ctries, 2009, 29 (2) : 80 -84.
  • 8Demant T, Seeberg K, Bedynek A, et al. The metabolism of lipoprotein (a) and other apolipoprotein B -containing lipoproteins: a kinetic study in humans [J]. Atheroseierosis, 2001, 157 (2): 1325-1339.
  • 9田延凤,马世瞻,孙文秀,马勇.早期糖尿病肾病患者血清抵抗素与血糖及血脂代谢的相关性分析[J].疑难病杂志,2011,10(6):453-454. 被引量:9
  • 10Yang CW, Park JT, Kim VL, et al. Prevalence of diabetic nephropa- thy in primary care type 2 diabetic patients with hypertension: data from the Korean Epidemiology Study on Hypertension Ⅲ( KEY Ⅲ study) [J]. Nephrelogy Diaysis Transplanation, 2011, 26 (10): 3249 - 3255.

二级参考文献55

  • 1卫生部疾病控制司,中华医学会糖尿病分会.中国糖尿病防治指南[M].北京:北京大学出版社,2004.3-4.
  • 2Schwarzer R,Schnell-lnderst P,Grabein K,et al.Prognostic value and clinical effectiveness of high sensitivity C-reactive protein as a marker in primary preventionof major cardiac events.Z Evid Fortbild Qual Gesundhwes,2009,103:319-329.
  • 3Yeh ET.High-sensitivity C-reactive protein as a risk assessment tool for cardiovascular disease.Clin Cardiol,2005,28:408-412.
  • 4Buckley DI,Fu R,Freeman M,et al.C-reactive protein as a risk factor for coronary heart disease:a systematic review and meta-analyses for the U.S.Ann Intern Med,2009,51:483-495.
  • 5Zieske AW,Tracy RP,Mcmahan CA,et al.Elevated serum Creactive protein levels and advanced atherosclerosis in youth.Arterioscler tromb Vasc Biol,2005,25:1237-1243.
  • 6Hoffmeister HM,Ehlera R,Buttcher E,et al.Relationship between minor myocardial damage and inflammatoxy acute.phase reaction in acute coronary syndromes.J Thromb Thromblysis,2003,15:33-39.
  • 7Gudnason V.Lipoprotein(a):a causal independent risk factor for coronary heart disease? Curt Opin Cardio1,2009,24:490-495.
  • 8Onat A,Hergen(c) G,Ozhan H,et al.Lipeprotein(a) is associated with coronary heart disease independent of metabolic syndrome.Coron Artery Dis,2008,19:125-131.
  • 9Baker JF,Krishnan E,Chen L,et al.Serum uric acid and cardiovascular disease:recent developments,and where do they leave us? Am J Med,2005,118:816-826.
  • 10Nelson RG,Tuttle KR.The new KDOQI clinical practice guidelines and clinical practice recommendations for diabetes and CKD[J].Blood Purif,2007,25(1):112-114.

共引文献96

同被引文献87

  • 1Masola V, Zaza G, Secchi MF,et al. Heparanase is a key player in renal fibrosis by regulating TGF expression and activity [J]. Biochim Biophys Acta, 2014, 1843(9):2122 2128.
  • 2Yao Z, Wang Y. Apolipoprotein C-III and hepatic triglyceride- rich lipoprotein production [J]. Curr ()pin Lipidol, 2012, 23 (3):206 212.
  • 3McKay GJ, Savage DA, Patterson CC, et al. Association anal- ysis of dyslipidemia-related genes in diabetic nephropathy[J]. PLoS One, 2013, 8(3) :e58472.
  • 4Li QC, Wang HY, Chen X, et al. Fasting plasma levels of nes latin 1 in patients with type 1 and type 2 diabetes mellitus and the nutrient related fluctuation of nesfatin-1 level in normal hu- mans[J]. Regul Pept, 2010, 159(1-3):72-77.
  • 5Krist J, Wieder K, Kl3 ring N, et al. Effects of weight loss and exercise on apelin serum concentrations and adipose tissue ex- pression in human obesity[J].Obes Facts. 2013; 6(1):57-69.
  • 6Schomaker S,Warner R, Bock J, et al. Assessment of emerging biomarkers of liver injury in human subjects [J]. Toxicol Sci, 2013, 132(2) :276-283.
  • 7Atay,A.E.,Akbas,H.,Tumer,C.et al.The association of en- dothelial nitric oxide synthase gene G894T polymorphism and serum nitric oxide concentration with microalbuminuria in patients with gestational diabetes[J].Clinical nephrology,2014,81(2):105-111.
  • 8Copeptin,a marker of vasopressin,in abdominal obesity,di- abetes and microalbuminuria:The prospective Malm? Diet and Cancer Study? cardiovascular cohort[J].International jour- nal of obesity,2013,37(4):598-603.
  • 9Galler,A.,Haberland,H.,N?ke,A.et al.Natural course of un- treated microalbuminuria in children and adolescents with type I diabetes and the importance of diabetes duration and immigrant status:Longitudinal analysis from the prospective nationwide German and Austrian diabetes sur- vey DPV[J].European journal of endocrinology,2012,166(3):493-501.
  • 10黄启亚,杨彩娴,李绍清.糖适平改善2型糖尿病患者β细胞功能临床观察[J].实用糖尿病杂志,2008,4(1):42-43. 被引量:3

引证文献10

二级引证文献112

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部